Differential Diagnosis and Strategy

18 Differential Diagnosis and Strategy

Solitary Focus

image

Common diagnoses. Focal adenosis, adenoma/fibroadenoma, papilloma.

Rare diagnoses. Lobulus, ductal carcinoma in situ (DCIS), invasive carcinoma, intramammary lymph node, phyllodes tumor.

Strategy. See Table 18.1.

image A solitary focus on breast MRI should preferably be followed up after 6 months. The risk of this lesion being malignant is somewhat higher than that of multiple foci. Should this focus be a malignant lesion, the expected lesion size after 6 months is maximally 5–6 mm. The initial performance of an MRI-guided vacuum-assisted biopsy (VAB) can and should be avoided.

TABLE 18.1 Diagnostic work-up strategy for solitary focus

Strategy: No correlative finding on mammography or breast ultrasound

Mx/US BI-RADS1

MRI follow-upa (Figs. 18.1, 18.2, 18.3).

Strategy: Correlative finding on mammography and/or breast ultrasoundb

Mx/US BI-RADS2

Mx or US follow-upa

Mx/US BI-RADS3

Mx or US follow-upa

Mx/US BI-RADS 4

Percutaneous biopsy (US-CB or Mx-VAB)

Mx/US BI-RADS 5

Percutaneous biopsy (US-CB or Mx-VAB)

a Follow-up interval usually 6 months.

b Small lesions often not found on second-look US.

Mx: x-ray mammography.

US: ultrasonography.

US-CB: US-guided core biopsy.

Mx-VAB: stereotactic vacuum-assisted biopsy.

Multiple Foci

image

Common diagnoses. Lobuli (physiological enhancement), adenosis, adenomas/fibroadenomas.

Rare diagnoses. Papillomas, DCIS, invasive carcinoma (one of the multiple foci), multiple carcinomas, intramammary metastases.

Strategy. See Table 18.2.

image Multiple foci on breast MRI should preferably be followed up in the normal early breast cancer detection interval of 1 year. Should one of these foci be a malignant lesion, the expected lesion size after 12 months is maximally 8–10 mm. The initial performance of an MRI-guided VAB is not expedient because “one will always biopsy the wrong focus.”

TABLE 18.2 Diagnostic work-up strategy for multiple foci

Strategy: No correlative finding on mammography or breast ultrasound

Mx/US BI-RADS1

Examination at routine intervals (Figs. 18.4, 18.5, 18.6).

Strategy: Correlative finding on mammography and/or breast ultrasound

Mx/US BI-RADS2

Examination at routine intervals

Mx/US BI-RADS3

Mx or US follow-upa

Mx/US BI-RADS 4

Percutaneous biopsy (US-CB or Mx-VAB)

Mx/US BI-RADS 5

Percutaneous biopsy (US-CB or Mx-VAB)

a Follow-up interval usually 6 months.

Mx: x-ray mammography. US: ultrasonography. US-CB: US-guided core biopsy. Mx-VAB: stereotactic vacuum-assisted biopsy.

Mass Lesion

image

Common diagnoses. Adenoma/fibroadenoma, adenosis, tumorforming adenosis, carcinoma, papilloma.

Rare diagnoses. Phyllodes tumor, hamartoma, granuloma, angiomatous hyperplasia, fibrosis, intramammary lymph node.

image

Strategy. See Table 18.5.

image

Mass Lesion—Differential Diagnosis

Rim-Enhancement (Figs. 18.7, 18.8, 18.9, 18.10)

image

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jul 31, 2016 | Posted by in OBSTETRICS | Comments Off on Differential Diagnosis and Strategy

Full access? Get Clinical Tree

Get Clinical Tree app for offline access